Between October 18–21, this website will move to a new web address (from health.gov to odphp.health.gov). During that time, some functions might not work as expected. We appreciate your patience and understanding as we’re working to make this transition as smooth as possible.

NCCC Meeting 7 Agenda

Time Session
1:00 pm – 1:05 pm Welcome, roll call, and review of the agenda

Jennifer A. Bishop, ScD., MPH
Designated Federal Officer
Office of Disease Prevention and Health Promotion
Office of the Assistant Secretary for Health
U.S. Department of Health and Human Services

Richard D. Olson, MD, MPH
Director, Division of Prevention Science
Office of Disease Prevention and Health Promotion
Office of the Assistant Secretary for Health
U.S. Department of Health and Human Services

William H. Herman, MD, MPH
Chair, National Clinical Care Commission
University of Michigan

1:05 pm – 1:10 pm Stakeholder Organization Public Comments Update

Clydette Powell, MD, MPH, FAAP
Office of Disease Prevention and Health Promotion
Office of the Assistant Secretary for Health
U.S. Department of Health and Human Services

1:10 pm – 1:15 pm Federal Data Call Update

Clydette Powell, MD, MPH, FAAP

1:15 pm – 2:15 pm Prevention—General Population Subcommittee Update

Dean Schillinger, MD
Chief, USCF Division of General Internal Medicine
San Francisco General Hospital

Ann Bullock, MD
Director, Division of Diabetes Treatment and Prevention
Indian Health Service

  • Summary from stakeholder organization calls
  • Input from data call/federal agencies
  • Synthesis and potential future direction
2:15 pm – 3:15 pm Prevention—Targeted Population Subcommittee Update

John Boltri, MD, FAAFP
Chair and Professor, Department of Family and Community Medicine
Northeast Ohio Medical University College of Medicine

Ann Albright, PhD, RDN
Division Director, Division of Diabetes Translation
Centers for Disease Control and Prevention

  • Summary from stakeholder organization calls
  • Input from data call/federal agencies
  • Synthesis and potential future direction
3:15 pm – 3:25 pm Break
3:25 pm – 4:25 pm Treatment and Complications Subcommittee Update

Carol Greenlee, MD, FACP, FACE
Faculty Co-Chair
Western Slope Endocrinology

Paul Conlin, MD
Chief, Medical Service
Veterans Affairs Boston Healthcare System

  • Summary from stakeholder organization calls
  • Input from data call/federal agencies
  • Synthesis and potential future direction
4:25 pm – 4:40 pm Oral Public Comments

William H. Herman, MD, MPH
Chair, National Clinical Care Commission

4:40 pm – 4:50 pm Meeting Review and Next Steps

William H. Herman, MD, MPH
Chair, National Clinical Care Commission

4:50 pm Adjournment